The neuronal chromatin landscape in adult schizophrenia brains is linked to early fetal development.
Kiran GirdharJaroslav BendlAndrew BaumgartnerKaren TherrienSanan VenkateshDeepika MathurPengfei DongSamir RahmanSteven KleopoulosRuth MisirSarah ReachPavan AuluckStefano MarencoDavid LewisVahram HaroutunianCory FunkGeorgios VoloudakisGabriel E HoffmanJohn F FullardPanagiotis RoussosPublished in: Research square (2023)
Non-coding variants increase risk of neuropsychiatric disease. However, our understanding of the cell-type specific role of the non-coding genome in disease is incomplete. We performed population scale (N=1,393) chromatin accessibility profiling of neurons and non-neurons from two neocortical brain regions: the anterior cingulate cortex and dorsolateral prefrontal cortex. Across both regions, we observed notable differences in neuronal chromatin accessibility between schizophrenia cases and controls. A per-sample disease pseudotime was positively associated with genetic liability for schizophrenia. Organizing chromatin into cis- and trans-regulatory domains, identified a prominent neuronal trans-regulatory domain (TRD1) active in immature glutamatergic neurons during fetal development. Polygenic risk score analysis using genetic variants within chromatin accessibility of TRD1 successfully predicted susceptibility to schizophrenia in the Million Veteran Program cohort. Overall, we present the most extensive resource to date of chromatin accessibility in the human cortex, yielding insights into the cell-type specific etiology of schizophrenia.
Keyphrases
- transcription factor
- bipolar disorder
- genome wide
- dna damage
- gene expression
- prefrontal cortex
- functional connectivity
- spinal cord
- copy number
- dna methylation
- cerebral ischemia
- endothelial cells
- resting state
- oxidative stress
- working memory
- quality improvement
- spinal cord injury
- multiple sclerosis
- transcranial magnetic stimulation
- brain injury
- high frequency
- blood brain barrier
- subarachnoid hemorrhage
- induced pluripotent stem cells